ZA986138B - Combinations of selective serotonin re-update inhibitors and B-blockers. - Google Patents

Combinations of selective serotonin re-update inhibitors and B-blockers.

Info

Publication number: ZA986138B
Authority: ZA; South Africa
Prior art keywords: blockers; inhibitors; update; combinations; selective serotonin
Prior art date: 1997-07-11

Application number

ZA9806138A

Other languages

English (en)

Inventor

Paul John Cummings

Ian Frederic Tulloch

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-11

Filing date

1998-07-10

Publication date

2000-01-10

1998-07-10 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2000-01-10 Publication of ZA986138B publication Critical patent/ZA986138B/xx

Links

QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title 2
239000003112 inhibitor Substances 0.000 title 1
229940076279 serotonin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Epidemiology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

ZA9806138A 1997-07-11 1998-07-10 Combinations of selective serotonin re-update inhibitors and B-blockers. ZA986138B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9714675.7A GB9714675D0 (en)	1997-07-11	1997-07-11	Novel composition

Publications (1)

Publication Number	Publication Date
ZA986138B true ZA986138B (en)	2000-01-10

Family

ID=10815744

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9806138A ZA986138B (en)	1997-07-11	1998-07-10	Combinations of selective serotonin re-update inhibitors and B-blockers.

Country Status (26)

Country	Link
EP (1)	EP0996466A2 (id)
JP (1)	JP2002508003A (id)
KR (1)	KR20010021644A (id)
CN (1)	CN1262627A (id)
AP (1)	AP2000001728A0 (id)
AR (1)	AR016128A1 (id)
AU (1)	AU9340198A (id)
BG (1)	BG104119A (id)
BR (1)	BR9810996A (id)
CA (1)	CA2295822A1 (id)
CO (1)	CO4950552A1 (id)
DZ (1)	DZ2556A1 (id)
EA (1)	EA200000112A1 (id)
GB (1)	GB9714675D0 (id)
HU (1)	HUP0003074A3 (id)
ID (1)	ID24191A (id)
IL (1)	IL133869A0 (id)
MA (1)	MA24604A1 (id)
NO (1)	NO20000107L (id)
OA (1)	OA11276A (id)
PE (1)	PE99699A1 (id)
PL (1)	PL338017A1 (id)
SK (1)	SK72000A3 (id)
TR (1)	TR200000074T2 (id)
WO (1)	WO1999002142A2 (id)
ZA (1)	ZA986138B (id)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE457169T1 (de)	1998-10-15	2010-02-15	Imp Innovations Ltd	Verbindungen für die behandlung von gewichtsverlust
EP1126826B3 (en)	1998-11-02	2019-05-15	Alkermes Pharma Ireland Limited	Multiparticulate modified release composition of methylphenidate
US10179130B2 (en)	1999-10-29	2019-01-15	Purdue Pharma L.P.	Controlled release hydrocodone formulations
AU764453B2 (en)	1999-10-29	2003-08-21	Euro-Celtique S.A.	Controlled release hydrocodone formulations
GB0004003D0 (en) *	2000-02-22	2000-04-12	Knoll Ag	Therapeutic agents
MXPA03003895A (es)	2000-10-30	2003-07-28	Euro Celtique Sa	Formulaciones de hidrocodona de liberacion controlada.
AU2005283829A1 (en) *	2004-09-17	2006-03-23	Neurocure Ltd	Pindolol for the treating premenstrual syndrome and premenstrual dysphoric disorder
CN100469356C (zh) *	2006-09-08	2009-03-18	山东益康药业有限公司	复方阿替洛尔缓释片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2732335C2 (de) *	1976-07-27	1983-01-20	Sandoz-Patent-GmbH, 7850 Lörrach	Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
CA2134038C (en) *	1994-06-16	1997-06-03	David Taiwai Wong	Potentiation of drug response
EP0714663A3 (en) *	1994-11-28	1997-01-15	Lilly Co Eli	Potentiation of drug responses by serotonin 1A receptor antagonists
ATE192042T1 (de) *	1995-08-16	2000-05-15	Lilly Co Eli	Potenzierung von serotonin-wirkstoffresponz
EP0792649A1 (en) *	1996-02-29	1997-09-03	Eli Lilly And Company	Treatment of sleep disorders

1997
- 1997-07-11 GB GBGB9714675.7A patent/GB9714675D0/en active Pending
1998
- 1998-07-07 EA EA200000112A patent/EA200000112A1/ru unknown
- 1998-07-07 TR TR2000/00074T patent/TR200000074T2/xx unknown
- 1998-07-07 WO PCT/EP1998/004971 patent/WO1999002142A2/en not_active Ceased
- 1998-07-07 CA CA002295822A patent/CA2295822A1/en not_active Abandoned
- 1998-07-07 KR KR1020007000202A patent/KR20010021644A/ko not_active Withdrawn
- 1998-07-07 CN CN98806975A patent/CN1262627A/zh active Pending
- 1998-07-07 BR BR9810996-0A patent/BR9810996A/pt not_active Application Discontinuation
- 1998-07-07 AP APAP/P/1999/001728A patent/AP2000001728A0/en unknown
- 1998-07-07 PL PL98338017A patent/PL338017A1/xx unknown
- 1998-07-07 EP EP98946294A patent/EP0996466A2/en not_active Withdrawn
- 1998-07-07 AU AU93401/98A patent/AU9340198A/en not_active Abandoned
- 1998-07-07 HU HU0003074A patent/HUP0003074A3/hu unknown
- 1998-07-07 JP JP50818599A patent/JP2002508003A/ja active Pending
- 1998-07-07 SK SK7-2000A patent/SK72000A3/sk unknown
- 1998-07-07 ID IDW20000035A patent/ID24191A/id unknown
- 1998-07-07 IL IL13386998A patent/IL133869A0/xx unknown
- 1998-07-08 DZ DZ980166A patent/DZ2556A1/xx active
- 1998-07-10 MA MA25165A patent/MA24604A1/fr unknown
- 1998-07-10 CO CO98039260A patent/CO4950552A1/es unknown
- 1998-07-10 PE PE1998000612A patent/PE99699A1/es not_active Application Discontinuation
- 1998-07-10 AR ARP980103371A patent/AR016128A1/es unknown
- 1998-07-10 ZA ZA9806138A patent/ZA986138B/xx unknown
2000
- 2000-01-10 NO NO20000107A patent/NO20000107L/no not_active Application Discontinuation
- 2000-01-11 OA OA1200000006A patent/OA11276A/en unknown
- 2000-02-01 BG BG104119A patent/BG104119A/xx unknown

Also Published As

Publication number	Publication date
TR200000074T2 (tr)	2000-05-22
CO4950552A1 (es)	2000-09-01
WO1999002142A3 (en)	1999-04-15
NO20000107D0 (no)	2000-01-10
NO20000107L (no)	2000-01-10
DZ2556A1 (fr)	2003-02-15
EA200000112A1 (ru)	2000-10-30
BG104119A (en)	2000-12-29
AP2000001728A0 (en)	2000-03-31
MA24604A1 (fr)	1999-04-01
CN1262627A (zh)	2000-08-09
GB9714675D0 (en)	1997-09-17
IL133869A0 (en)	2001-04-30
CA2295822A1 (en)	1999-01-21
PL338017A1 (en)	2000-09-25
OA11276A (en)	2003-07-31
JP2002508003A (ja)	2002-03-12
KR20010021644A (ko)	2001-03-15
SK72000A3 (en)	2000-12-11
HUP0003074A2 (hu)	2001-01-29
AU9340198A (en)	1999-02-08
EP0996466A2 (en)	2000-05-03
AR016128A1 (es)	2001-06-20
BR9810996A (pt)	2000-08-08
ID24191A (id)	2000-07-13
WO1999002142A2 (en)	1999-01-21
PE99699A1 (es)	1999-12-21
HUP0003074A3 (en)	2001-12-28

Publication	Publication Date	Title
ZA973146B (en)	1998-04-14	Prodrugs of COX-2 inhibitors.
IL121076A (en)	2000-10-31	Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
ID23983A (id)	2000-06-14	Inhibitor-inhibitor aminotiazol untuk kinase-kinase tergantung siklin
ZA973397B (en)	1997-11-14	Inhibitors of IMPDH enzyme.
IL147246A0 (en)	2002-08-14	Highly selective norepinephrine reuptake inhibitors and methods of using the same
ZA985778B (en)	2000-01-20	Inhibitors of farnesyl protein transferase.
NO20001651L (no)	2000-06-05	Nedlasting av data
IL138387A0 (en)	2001-10-31	Enzyme inhibitors
BR0001422B1 (pt)	2012-12-25	aparelho e mÉtodo de reproduÇço.
DE69820138D1 (de)	2004-01-15	Methode pour stimuler des formations souterraines non consolidees
ZA200109994B (en)	2002-10-30	Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors.
ID20637A (id)	1999-02-04	Metode untuk menghambat pembentukan sulfida biogenik
DK1027332T3 (da)	2004-10-04	Hidtil ukendte lactametalloproteaseinhibitorer
PL334846A1 (en)	2000-03-27	Sulphamidic inhibitors of metaloproteases
NO20012691D0 (no)	2001-05-31	Isomerisering av hydrokarboner
NO996090L (no)	2000-01-18	Forbedret foskefor og fremgangsmåte for anvendelse av dette
HUP0101640A3 (en)	2002-10-28	Certain thoil inhibitors of endothelin-converting enzyme
AU4231699A (en)	2000-01-05	Inhibitors of serotonin reuptake
ZA986138B (en)	2000-01-10	Combinations of selective serotonin re-update inhibitors and B-blockers.
ZA977868B (en)	1998-03-30	Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors.
TR199501644A2 (tr)	1996-11-21	Skualen sintetaz inhibitörleri.
GB9816358D0 (en)	1998-09-23	Enzyme inhibitors
EP0976720A4 (en)	2002-03-06	propanolamine
ITBO970057A0 (it)	1997-02-11	Metodo di controllo di sigarette.
NO20001569L (no)	2000-03-24	Bisetere av 1-oksa, aza og tianaftalen-2-oner som fosfolambaninhibitorer